Role of the angiotensin II type 2 receptor gene (+1675G/A) polymorphism on left ventricular hypertrophy and geometry in treated hypertensive patients

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Hypertension

• Publication date

  2010-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/HJH.0b013e32833aa356PMID 20467270
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The aging hypertensive heart: a brief update

  2008cited by this paper
• AT2 receptors: Functional relevance in cardiovascular disease

  2008cited by this paper
• Development of heart failure in recent hypertension trials

  2008cited by this paper
• The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study.

  2008cited by this paper
• Angiotensin II Type 2 Receptor Stimulation: A Novel Option of Therapeutic Interference With the Renin-Angiotensin System in Myocardial Infarction?

  2008cited by this paper
• Marked Regional Left Ventricular Heterogeneity in Hypertensive Left Ventricular Hypertrophy Patients: A Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Cardiovascular Magnetic Resonance and Echocardiographic Substudy

  2008cited by this paper
• Left ventricular hypertrophy and clinical outcomes in hypertensive patients.

  2008cited by this paper
• High sodium intake modulates left ventricular mass in patients with G expression of +1675 G/A angiotensin II receptor type 2 gene

  2007cited by this paper
• 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension.

  2007cited by this paper
• Inappropriate Left Ventricular Mass Changes During Treatment Adversely Affects Cardiovascular Prognosis in Hypertensive Patients

  2007cited by this paper
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

  2007cited by this paper
• Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

  2007cited by this paper
• ECM remodeling in hypertensive heart disease.

  2007cited by this paper
• Effect of a common X-linked angiotensin II type 2-receptor gene polymorphism (-1332 G/A) on the occurrence of premature myocardial infarction and stenotic atherosclerosis requiring revascularization.

  2007cited by this paper
• Antihypertensive strategy based on angiotensin II receptor blockers: a new gateway to reduce risk in hypertension

  2007cited by this paper
• Physiology of local renin-angiotensin systems.

  2006cited by this paper
• The Angiotensin II Type 2 Receptor Causes Constitutive Growth of Cardiomyocytes and Does Not Antagonize Angiotensin II Type 1 Receptor–Mediated Hypertrophy

  2005cited by this paper
• The continuing saga of the AT2 receptor: a case of the good, the bad, and the innocuous.

  2005cited by this paper
• The clinical significance of a common, functional, X-linked angiotensin II type 2-receptor gene polymorphism (-1332 G/A) in a cohort of 509 families with premature coronary artery disease.

  2005cited by this paper
• The AT2 receptor--a matter of love and hate.

  2005cited by this paper
• Intronic ANG II type 2 receptor gene polymorphism 1675 G/A modulates receptor protein expression but not mRNA splicing.

  2005cited by this paper
• Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study.

  2005cited by this paper
• Update on the role of the AT2 receptor

  2005cited by this paper
• American Society of Echocardiography recommendations for use of echocardiography in clinical trials.

  2004cited by this paper
• Genes for left ventricular hypertrophy

  2004cited by this paper
• Left Ventricular Concentric Geometry During Treatment Adversely Affects Cardiovascular Prognosis in Hypertensive Patients

  2004cited by this paper
• Assessment of ventricular function and mass by cardiac magnetic resonance imaging

  2004cited by this paper
• Left Ventricular Mass in Relation to Genetic Variation in Angiotensin II Receptors, Renin System Genes, and Sodium Excretion

  2004cited by this paper
• Cardiac angiotensin AT2 receptor: what exactly does it do?

  2004cited by this paper
• Left Ventricle Mass Index and the Common, Functional, X-Linked Angiotensin II Type-2 Receptor Gene Polymorphism (−1332 G/A) in Patients With Systemic Hypertension

  2004cited by this paper
• Pharmacogenetics of antihypertensive drug response

  2004cited by this paper
• Angiotensin AT2 receptors: cardiovascular hope or hype?

  2003cited by this paper
• A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.

  2003cited by this paper
• National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification

  2003cited by this paper
• Polymorphisms in the RAS and cardiac function.

  2003cited by this paper
• Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular disease?

  2003cited by this paper
• Genetic Loci Contribute to the Progression of Vascular and Cardiac Hypertrophy in Salt-Sensitive Spontaneous Hypertension

  2003cited by this paper
• Angiotensin AT1/AT2 Receptors: Regulation, Signalling and Function

  2003cited by this paper
• Genetic Variants of Angiotensin II Receptors and Cardiovascular Risk in Hypertension

  2003cited by this paper
• Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial

  2002cited by this paper
• Angiotensin II type 2 receptor gene polymorphism and cardiovascular phenotypes: the GLAECO and GLAOLD studies

  2002cited by this paper
• Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans.

  2001cited by this paper
• Angiotensin II Type 2 Receptor Is Essential for Left Ventricular Hypertrophy and Cardiac Fibrosis in Chronic Angiotensin II–Induced Hypertension

  2001cited by this paper
• Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide.

  2001cited by this paper
• A new statistical method for haplotype reconstruction from population data.

  2001cited by this paper
• Renin-angiotensin system gene polymorphisms: potential mechanisms for their association with cardiovascular diseases.

  2000cited by this paper
• Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload.

  2000cited by this paper
• Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload

  2000cited by this paper
• 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

  1999cited by this paper
• Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men.

  1999cited by this paper
• Differential distribution of angiotensin AT2 receptors in the normal and failing human heart.

  1998cited by this paper
• Differential Distribution of Angiotensin AT 2 Receptors in the Normal and Failing Human Heart 1

  1997cited by this paper
• Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension.

  1996cited by this paper
• Angiotensin II type 1 receptor A/C1166 polymorphism. Relationships with blood pressure and cardiovascular structure.

  1996cited by this paper
• Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy.

  1996cited by this paper
• The renin-angiotensin system in left ventricular remodeling.

  1996cited by this paper
• A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease.

  1995cited by this paper
• The sequence and genomic organization of the human type 2 angiotensin II receptor.

  1995cited by this paper
• Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk.

  1995cited by this paper
• Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

  1986cited by this paper
• Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements

  1978cited by this paper

• The rs1403543 Polymorphism of AGTR2, Which Encodes the Type-2 Angiotensin II Receptor, and Left Ventricular Mass in Polish Full-Term Newborns

  2025influential citation
• Association of the Single Nucleotide Polymorphisms in the Renin-Angiotensin-Aldosterone System with Hypertension in the Uzbek Population.

  2024influential citation
• Uromodulin associates with cardiorenal function in patients with hypertension and cardiovascular disease

  2017cites this paper
• Regulation of podoplanin expression by microRNA-29b associates with its antiapoptotic effect in angiotensin II-induced injury of human podocytes

  2016cites this paper
• Recent Advances in the Genetics of Hypertension.

  2016cites this paper
• The utility of copy number variation (CNV) in studies of hypertension-related left ventricular hypertrophy (LVH): rationale, potential and challenges

  2013cites this paper
• Genetic variants implicated in telomere length associated with left ventricular function in patients with hypertension and cardiac organ damage

  2012cites this paper
• Context-dependent effects of the angiotensin II type 2 receptor gene on left ventricular remodelling: the story continues.

  2010cites this paper
• Nature Publishing Group Original Contributions Are Retinal Microvascular Phenotypes Associated with the 1675g/a Polymorphism in the Angiotensin Ii Type-2 Receptor Gene?

  year unknowncites this paper